Allergen Pack Dermatophagoides Pteronyssinus Solution

Allergen Pack Dermatophagoides Pteronyssinus Solution

Allergen Pack Dermatophagoides Pteronyssinus Solution Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

Carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)]

1.1 Osteoarthritis (OA)

Celecoxib is indicated for relief of the signs and symptoms of OA [see Clinical Studies (14.1)]

1.2 Rheumatoid Arthritis (RA)

Celecoxib is indicated for relief of the signs and symptoms of RA [see Clinical Studies (14.2)]

1.3 Juvenile Rheumatoid Arthritis (JRA)

Celecoxib is indicated for relief of the signs and symptoms of JRA in patients 2 years and older [see Clinical Studies (14.3)]

1.4 Ankylosing Spondylitis (AS)

Celecoxib is indicated for the relief of signs and symptoms of AS [see Clinical Studies (14.4)]

1.5 Acute Pain (AP)

Celecoxib is indicated for the management of AP in adults [see Clinical Studies (14.5)]

1.6 Primary Dysmenorrhea (PD)

Celecoxib is indicated for the treatment of PD [see Clinical Studies (14.5)]

History

There is currently no drug history available for this drug.

Other Information

Celecoxib is chemically designated as 4-[5-(4-methylphenyl)- 3-(trifluoromethyl)-1H-pyrazol-1-yl] benzenesulfonamide and is a diaryl-substituted pyrazole. The empirical formula is C17H14F3N3O2S, and the molecular weight is 381.38; the chemical structure is as follows:

Chemical Structure

Celecoxib oral capsules contain either 50 mg, 100 mg, 200 mg or 400 mg of celecoxib, together with inactive ingredients including: croscarmellose sodium, edible inks, gelatin, lactose monohydrate, magnesium stearate, povidone and sodium lauryl sulfate.

Allergen Pack Dermatophagoides Pteronyssinus Solution Manufacturers


  • Alvix Laboratories, Llc
    Allergen Pack Dermatophagoides Pteronyssinus Solution [Alvix Laboratories, Llc]

Login To Your Free Account